Pertuzumab
FDA okays GSK’s Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma’s India facility

FDA okays GSK’s Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma’s India facility

As the year draws to a close, the US Food and Drug Administration (FDA) appears busy approving drugs at a fast pace. This week...

Impressions : 1488

Top drugs and pharmaceutical companies of 2018 by revenues

The drug pricing debate continued to dominate news headlines in 2018, and many companies were in the news for lowering drug pri...

Impressions : 35120